Class II/III Obesity Prevalence in Residents of US Nursing Homes : Cross-sectional Study and Forecasting 2030 with COVID-19 Perspective
OBJECTIVES: This study aimed to better understand Class II/III obesity prevalence trends among older adults residing in nursing homes (NH) nationwide.
METHODS: Our retrospective cross-sectional study evaluated Class II/III obesity (BMI ≥35 kg/m²) prevalence among NH residents in two independent national NH cohorts. We used databases from Veterans Administration NHs called Community Living Centers (CLCs) covering 7 years to 2022, and Rhode Island Medicare data covering 20 years ending in 2020. We also performed forecasting regression analysis of obesity trends.
RESULTS: While VA CLC resident obesity prevalence was less overall and dipped during the COVID-19 pandemic, obesity prevalence increased in NH residents in both cohorts over the last decade and is predicted to do so through 2030.
CONCLUSION: Obesity prevalence in NHs is on the rise. It will be important to understand clinical, functional, and financial implications for NHs, particularly if predictions on increases materialize.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:106 |
|---|---|
| Enthalten in: |
Rhode Island medical journal (2013) - 106(2023), 4 vom: 01. Mai, Seite 25-29 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Abul, Yasin [VerfasserIn] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 27.04.2023 Date Revised 27.04.2023 published: Electronic Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM35601794X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM35601794X | ||
| 003 | DE-627 | ||
| 005 | 20231226065553.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n1186.xml |
| 035 | |a (DE-627)NLM35601794X | ||
| 035 | |a (NLM)37098143 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Abul, Yasin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Class II/III Obesity Prevalence in Residents of US Nursing Homes |b Cross-sectional Study and Forecasting 2030 with COVID-19 Perspective |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.04.2023 | ||
| 500 | |a Date Revised 27.04.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a OBJECTIVES: This study aimed to better understand Class II/III obesity prevalence trends among older adults residing in nursing homes (NH) nationwide | ||
| 520 | |a METHODS: Our retrospective cross-sectional study evaluated Class II/III obesity (BMI ≥35 kg/m²) prevalence among NH residents in two independent national NH cohorts. We used databases from Veterans Administration NHs called Community Living Centers (CLCs) covering 7 years to 2022, and Rhode Island Medicare data covering 20 years ending in 2020. We also performed forecasting regression analysis of obesity trends | ||
| 520 | |a RESULTS: While VA CLC resident obesity prevalence was less overall and dipped during the COVID-19 pandemic, obesity prevalence increased in NH residents in both cohorts over the last decade and is predicted to do so through 2030 | ||
| 520 | |a CONCLUSION: Obesity prevalence in NHs is on the rise. It will be important to understand clinical, functional, and financial implications for NHs, particularly if predictions on increases materialize | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a nursing homes | |
| 650 | 4 | |a obesity | |
| 700 | 1 | |a DeVone, Frank |e verfasserin |4 aut | |
| 700 | 1 | |a Singh, Mriganka |e verfasserin |4 aut | |
| 700 | 1 | |a Halladay, Christopher |e verfasserin |4 aut | |
| 700 | 1 | |a Bayer, Thomas A |e verfasserin |4 aut | |
| 700 | 1 | |a McConeghy, Kevin W |e verfasserin |4 aut | |
| 700 | 1 | |a Gravenstein, Stefan |e verfasserin |4 aut | |
| 700 | 1 | |a Rudolph, James L |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Rhode Island medical journal (2013) |d 2013 |g 106(2023), 4 vom: 01. Mai, Seite 25-29 |w (DE-627)NLM227172663 |x 2327-2228 |7 nnns |
| 773 | 1 | 8 | |g volume:106 |g year:2023 |g number:4 |g day:01 |g month:05 |g pages:25-29 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 106 |j 2023 |e 4 |b 01 |c 05 |h 25-29 | ||